Gary C. Chamness

14.4k total citations · 5 hit papers
95 papers, 11.3k citations indexed

About

Gary C. Chamness is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Gary C. Chamness has authored 95 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Genetics, 41 papers in Molecular Biology and 38 papers in Oncology. Recurrent topics in Gary C. Chamness's work include Estrogen and related hormone effects (48 papers), HER2/EGFR in Cancer Research (27 papers) and Breast Cancer Treatment Studies (17 papers). Gary C. Chamness is often cited by papers focused on Estrogen and related hormone effects (48 papers), HER2/EGFR in Cancer Research (27 papers) and Breast Cancer Treatment Studies (17 papers). Gary C. Chamness collaborates with scholars based in United States, Netherlands and Switzerland. Gary C. Chamness's co-authors include William McGuire, Gary M. Clark, Suzanne A.W. Fuqua, C. Kent Osborne, Richard Elledge, Susan G. Hilsenbeck, Jenny C. Chang, D. Craig Allred, Atul K. Tandon and D. Craig Allred and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Gary C. Chamness

95 papers receiving 10.7k citations

Hit Papers

Intrinsic Resistance of Tumorigenic Breas... 1989 2026 2001 2013 2008 1993 2003 2003 1989 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
    2008 1.4k citations Michael T. Lewis, Jian Huang et al. JNCI Journal of the National Cancer Institute profile →
  2. Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast Cancer
    1993 683 citations D. Craig Allred, Gary M. Clark et al. JNCI Journal of the National Cancer Institute profile →
  3. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
    2003 668 citations Jenny C. Chang, Susan G. Hilsenbeck et al. profile →
  4. Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast Cancer
    2003 642 citations C. Kent Osborne, Gary C. Chamness et al. JNCI Journal of the National Cancer Institute profile →
  5. HER-2/neu oncogene protein and prognosis in breast cancer.
    1989 497 citations Amol Tandon, Gary M. Clark et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary C. Chamness United States 48 5.7k 4.9k 3.6k 3.4k 1.2k 95 11.3k
Lambert Skoog Sweden 50 4.3k 0.7× 3.8k 0.8× 2.9k 0.8× 3.5k 1.0× 1.6k 1.3× 270 10.3k
Robert I. Nicholson United Kingdom 74 9.4k 1.6× 8.1k 1.7× 4.9k 1.3× 4.3k 1.3× 2.9k 2.4× 262 18.4k
Suzanne A.W. Fuqua United States 69 6.4k 1.1× 9.3k 1.9× 6.6k 1.8× 4.0k 1.2× 1.8k 1.5× 203 16.6k
Robert B. Dickson United States 73 5.9k 1.0× 8.9k 1.8× 4.3k 1.2× 3.6k 1.1× 871 0.7× 221 16.1k
Leigh C. Murphy Canada 62 3.2k 0.6× 5.7k 1.2× 4.6k 1.3× 2.0k 0.6× 736 0.6× 207 10.5k
Rosette Lidereau France 70 6.3k 1.1× 9.5k 2.0× 3.3k 0.9× 5.0k 1.5× 1.9k 1.6× 263 16.1k
Henri Rochefort France 68 3.5k 0.6× 6.7k 1.4× 5.9k 1.6× 3.9k 1.1× 546 0.5× 266 13.5k
Elizabeth A. Musgrove Australia 60 6.6k 1.2× 7.4k 1.5× 3.0k 0.8× 3.2k 0.9× 2.3k 1.9× 144 13.6k
Simak Ali United Kingdom 55 4.2k 0.7× 7.3k 1.5× 4.8k 1.3× 2.3k 0.7× 1.5k 1.2× 157 11.8k
Christopher C. Benz United States 59 5.2k 0.9× 9.1k 1.9× 1.7k 0.5× 4.4k 1.3× 1.1k 0.9× 197 14.8k

Countries citing papers authored by Gary C. Chamness

Since Specialization
Citations

This map shows the geographic impact of Gary C. Chamness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary C. Chamness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary C. Chamness more than expected).

Fields of papers citing papers by Gary C. Chamness

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary C. Chamness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary C. Chamness. The network helps show where Gary C. Chamness may publish in the future.

Co-authorship network of co-authors of Gary C. Chamness

This figure shows the co-authorship network connecting the top 25 collaborators of Gary C. Chamness. A scholar is included among the top collaborators of Gary C. Chamness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary C. Chamness. Gary C. Chamness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bu, Wen, Jun Chen, Shixia Huang, et al.. (2011). Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer. Oncogene. 30(43). 4399–4409. 43 indexed citations
2.
Lewis, Michael T., Jian Huang, Carolina Gutiérrez, et al.. (2008). Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy. JNCI Journal of the National Cancer Institute. 100(9). 672–679. 1418 indexed citations breakdown →
3.
Creighton, Chad J., C. Kent Osborne, Marc J. van de Vijver, et al.. (2008). Molecular profiles of progesterone receptor loss in human breast tumors. Breast Cancer Research and Treatment. 114(2). 287–299. 91 indexed citations
4.
Zhang, Xiaomei, Katrina Podsypanina, Shixia Huang, et al.. (2005). Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations. Oncogene. 24(26). 4220–4231. 42 indexed citations
5.
Mohsin, Syed K., Maya Gutierrez, Heidi L. Weiss, et al.. (2005). Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers. Breast Cancer Research and Treatment. 94(3). 279–284. 20 indexed citations
6.
Lee, Adrian V., Gary C. Chamness, & Steffi Oesterreich. (2004). 26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3–6 December 2003: update on preclinical and translational research. Breast Cancer Research. 6(2). E10–E10. 2 indexed citations
7.
Elledge, Richard, Gary M. Clark, Gary C. Chamness, & C. Kent Osborne. (1994). Tumor Biologic Factors and Breast Cancer Prognosis Among White, Hispanic, and Black Women in the United States. JNCI Journal of the National Cancer Institute. 86(9). 705–712. 357 indexed citations
8.
Ravdin, Peter M., Amol Tandon, D. Craig Allred, et al.. (1994). Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer.. Journal of Clinical Oncology. 12(3). 467–474. 47 indexed citations
9.
Fuqua, Suzanne A.W., et al.. (1994). Constitutive overexpression of the 27,000 dalton heat shock protein in late passage human breast cancer cells. Breast Cancer Research and Treatment. 32(2). 177–186. 16 indexed citations
10.
Molina, Rafael, Daniel R. Ciocca, Amol Tandon, et al.. (1993). Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and western blot techniques.. PubMed. 12(6B). 1965–71. 49 indexed citations
11.
Allred, D. Craig, Gary M. Clark, Richard Elledge, et al.. (1993). Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast Cancer. JNCI Journal of the National Cancer Institute. 85(3). 200–206. 683 indexed citations breakdown →
12.
Fuqua, Suzanne A.W., Gary C. Chamness, & William McGuire. (1993). Estrogen receptor mutations in breast cancer. Journal of Cellular Biochemistry. 51(2). 135–139. 94 indexed citations
13.
McGuire, William, et al.. (1992). Prognosis and treatment decisions in patients with breast cancer without axillary node involvement. Cancer. 70(S4). 1775–1781. 26 indexed citations
14.
McGuire, William, Gary C. Chamness, & Suzanne A.W. Fuqua. (1992). Abnormal estrogen receptor in clinical breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 43(1-3). 243–247. 61 indexed citations
15.
Fuqua, Suzanne A.W., et al.. (1991). Progesterone Receptor Gene Restriction Fragment Length Polymorphisms in Human Breast Tumors. JNCI Journal of the National Cancer Institute. 83(16). 1157–1160. 17 indexed citations
16.
Salman, Mohammad, et al.. (1991). 17α -Substituted analogs of estradiol for the development of fluorescent estrogen receptor ligands. Steroids. 56(7). 375–387. 27 indexed citations
17.
Salman, Mohammad & Gary C. Chamness. (1991). A potential radioiodinated ligand for androgen receptor: 7.alpha.-methyl-17.alpha.-[2'-(E)-iodovinyl]-19-nortestosterone. Journal of Medicinal Chemistry. 34(3). 1019–1024. 10 indexed citations
18.
McGuire, William, Atul K. Tandon, D. Craig Allred, Gary C. Chamness, & Gary M. Clark. (1990). How To Use Prognostic Factors in Axillary Node-Negative Breast Cancer Patients. JNCI Journal of the National Cancer Institute. 82(12). 1006–1015. 258 indexed citations
19.
Tandon, Atul K., Gary M. Clark, Gary C. Chamness, John M. Chirgwin, & William McGuire. (1990). Cathepsin D and Prognosis in Breast Cancer. New England Journal of Medicine. 322(5). 297–302. 385 indexed citations
20.
Tandon, Amol, et al.. (1989). HER-2/neu oncogene protein and prognosis in breast cancer.. Journal of Clinical Oncology. 7(8). 1120–1128. 497 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lambert Skoog Breakdown of academic impact, for papers by Robert I. Nicholson Breakdown of academic impact, for papers by Suzanne A.W. Fuqua Breakdown of academic impact, for papers by Robert B. Dickson Breakdown of academic impact, for papers by Leigh C. Murphy Breakdown of academic impact, for papers by Rosette Lidereau Breakdown of academic impact, for papers by Henri Rochefort Breakdown of academic impact, for papers by Elizabeth A. Musgrove Breakdown of academic impact, for papers by Simak Ali Breakdown of academic impact, for papers by Christopher C. Benz
Rankless by CCL
2026